These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial. Bosso JA; Nappi J; Rudisill C; Wellein M; Bookstaver PB; Swindler J; Mauldin PD Antimicrob Agents Chemother; 2011 Dec; 55(12):5475-9. PubMed ID: 21947388 [TBL] [Abstract][Full Text] [Related]
6. Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy. Wong-Beringer A; Joo J; Tse E; Beringer P Int J Antimicrob Agents; 2011 Feb; 37(2):95-101. PubMed ID: 21130609 [TBL] [Abstract][Full Text] [Related]
7. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia. Mogle BT; Steele JM; Seabury RW; Dang UJ; Kufel WD Int J Antimicrob Agents; 2018 Dec; 52(6):805-810. PubMed ID: 30176357 [TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections. Hermsen ED; Hanson M; Sankaranarayanan J; Stoner JA; Florescu MC; Rupp ME Expert Opin Drug Saf; 2010 Jan; 9(1):9-14. PubMed ID: 20021290 [TBL] [Abstract][Full Text] [Related]
9. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Elyasi S; Khalili H; Dashti-Khavidaki S; Mohammadpour A Eur J Clin Pharmacol; 2012 Sep; 68(9):1243-55. PubMed ID: 22411630 [TBL] [Abstract][Full Text] [Related]
10. Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections? van Hal SJ; Fowler VG Clin Infect Dis; 2013 Jun; 56(12):1779-88. PubMed ID: 23511300 [TBL] [Abstract][Full Text] [Related]
11. Balancing vancomycin efficacy and nephrotoxicity: should we be aiming for trough or AUC/MIC? Patel K; Crumby AS; Maples HD Paediatr Drugs; 2015 Apr; 17(2):97-103. PubMed ID: 25644329 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of body weight-based vancomycin therapy and the incidence of nephrotoxicity: a retrospective study in the northwest of China. Dong MH; Wang JW; Wu Y; Chen BY; Yu M; Wen AD Int J Infect Dis; 2015 Aug; 37():125-8. PubMed ID: 26159843 [TBL] [Abstract][Full Text] [Related]
13. The Whole Price of Vancomycin: Toxicities, Troughs, and Time. Jeffres MN Drugs; 2017 Jul; 77(11):1143-1154. PubMed ID: 28573434 [TBL] [Abstract][Full Text] [Related]
14. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Rybak MJ; Le J; Lodise TP; Levine DP; Bradley JS; Liu C; Mueller BA; Pai MP; Wong-Beringer A; Rotschafer JC; Rodvold KA; Maples HD; Lomaestro BM Pharmacotherapy; 2020 Apr; 40(4):363-367. PubMed ID: 32227354 [TBL] [Abstract][Full Text] [Related]
15. A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study. Kalimuddin S; Chan YFZ; Phillips R; Ong SP; Archuleta S; Lye DC; Tan TT; Low JGH Trials; 2018 Jun; 19(1):305. PubMed ID: 29859132 [TBL] [Abstract][Full Text] [Related]
16. Impact of pharmacist intervention on preventing nephrotoxicity from vancomycin. Masuda N; Maiguma T; Komoto A; Haruki Y; Sugiyama T; Kondo S; Teshima D Int J Clin Pharmacol Ther; 2015 Apr; 53(4):284-91. PubMed ID: 25740266 [TBL] [Abstract][Full Text] [Related]
17. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center. Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349 [TBL] [Abstract][Full Text] [Related]
18. Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis. Steinmetz T; Eliakim-Raz N; Goldberg E; Leibovici L; Yahav D Clin Microbiol Infect; 2015 Jul; 21(7):665-73. PubMed ID: 25887712 [TBL] [Abstract][Full Text] [Related]
19. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients. Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Rybak MJ; Lomaestro BM; Rotschafer JC; Moellering RC; Craig WA; Billeter M; Dalovisio JR; Levine DP Pharmacotherapy; 2009 Nov; 29(11):1275-9. PubMed ID: 19873687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]